Journal of Alzheimer's disease : JAD · 2022
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance.
Blivet et al.
PhotobiomodulationClinical trial
- Journal
- Journal of Alzheimer's disease : JAD
- Year
- 2022
- Publication type
- Randomized Controlled Trial|Journal Article|Research Support, Non-U.S. Gov't